Priothera

PITCH
We are dedicated to improving the lives of patients suffering from hematological malignancies by delivering an innovative immune modulator to enhance the curative potential of allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in these patients.
LATEST INVESTMENT
#Healthtech
10.2020
Priothera
£26.8M
Fountain Healthcare Partners, HealthCap, Tekla Capital Management, LLC and EarlyBird Venture Capital